linfoma anaplásico

Groth, A; Graf, R.
Aesthetic Plastic Surgery, February 2020, Volume 44, Issue 1

portada - Aesthetic Plastic Surgery - Vol. 41; No. 2 (2017)Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon T-cell, CD-30+/ALK lymphoma. Late (9 years) periprosthetic fluid (seroma) is the most common presentation (90% of the cases). A combination of textured breast implant, bacterial contamination, and genetic predisposition seems to be necessary for BIA-ALCL to occur. There are 35 million patients with implants in the world, and at the present moment, 573 cases of BIA-ALCL have been reported.

Doren, E. L. et als.
Plastic & Reconstructive Surgery – May 2017 – Volume 139 – Issue 9 – p 1042–1050

portada - PRS - Vol. 132; No. 2 (2013)Breast implant–associated anaplastic large cell lymphoma (ALCL) is a distinctive type of T-cell lymphoma that arises around breast implants. Although rare, all cases with adequate history have involved a textured breast implant. The objective of this study was to determine the U.S. incidence and lifetime prevalence of breast implant–associated ALCL in women with textured breast implants.
This study demonstrates a statistically significant association between textured breast implants and breast implant–associated ALCL. Although women with a textured breast implant have a low risk of developing breast implant–associated ALCL, the current U.S. incidence is significantly higher than that of primary ALCL of the breast in the general population.

Benjamin, K. et als.
Plastic and Reconstructive Surgery – Global Open. 2015;3(1):e296.

PRS Global Open - Vol. 3Despite increased cases published on breast implant–associated anaplastic large cell lymphoma (BIA-ALCL), important clinical issues remain unanswered. We conducted a second structured expert consultation process to rate statements related to the diagnosis, management, and surveillance of this disease, based on their interpretation of published evidence.